Conflicting evidence on the efficacy of hydroxychloroquine and azithromycin as the early treatment of COVID-19. Comment on "Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France"

Travel Med Infect Dis. 2020 Sep-Oct:37:101861. doi: 10.1016/j.tmaid.2020.101861. Epub 2020 Sep 1.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Azithromycin / therapeutic use
  • Betacoronavirus
  • COVID-19
  • COVID-19 Drug Treatment
  • Coronavirus Infections* / drug therapy
  • France
  • Humans
  • Hydroxychloroquine* / therapeutic use
  • Pandemics*
  • Pneumonia, Viral*
  • Retrospective Studies
  • SARS-CoV-2

Substances

  • Hydroxychloroquine
  • Azithromycin